API australian pharmaceutical industries limited

Ann: API Market Update - 1H15 forecast, page-3

  1. 3,053 Posts.
    lightbulb Created with Sketch. 7
    Based on this latest update could estimate full year NPAT of around $42 million. Based on market cap of around $650 million after today's 7% jump gives a PE of around 15. Not exceptionally high for a company achieving 30% NPAT growth over previous year. Dividends should also increase. This is in a great sector (health, beauty, pharmaceuticals), I would expect there is room for this stock to go quite a bit higher yet.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.